Clinical Trial Update: Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring adebrelimab in combination with the AG regimen (nab-paclitaxel + gemcitabine) for unresectable locally advanced or metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Jin Xu | Conditions: Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING